Champions Oncology Inc (CSBR)
4.70
-0.03
(-0.63%)
USD |
NASDAQ |
May 17, 16:00
Champions Oncology Net Income (Quarterly): -2.53M for Jan. 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -2.53M |
| October 31, 2023 | -2.071M |
| July 31, 2023 | -2.566M |
| April 30, 2023 | -2.561M |
| January 31, 2023 | -2.439M |
| October 31, 2022 | -0.016M |
| July 31, 2022 | -0.319M |
| April 30, 2022 | -0.344M |
| January 31, 2022 | 0.787M |
| October 31, 2021 | 0.277M |
| July 31, 2021 | -0.172M |
| April 30, 2021 | -0.673M |
| January 31, 2021 | 0.959M |
| October 31, 2020 | 0.001M |
| July 31, 2020 | 0.075M |
| April 30, 2020 | -2.165M |
| January 31, 2020 | 0.407M |
| October 31, 2019 | 0.307M |
| July 31, 2019 | -0.641M |
| April 30, 2019 | -0.253M |
| January 31, 2019 | -0.369M |
| October 31, 2018 | 0.267M |
| July 31, 2018 | 0.482M |
| April 30, 2018 | -0.632M |
| January 31, 2018 | -0.076M |
| Date | Value |
|---|---|
| October 31, 2017 | -0.094M |
| July 31, 2017 | -0.674M |
| April 30, 2017 | -2.424M |
| January 31, 2017 | -1.409M |
| October 31, 2016 | -0.504M |
| July 31, 2016 | -2.546M |
| April 30, 2016 | -2.574M |
| January 31, 2016 | -2.412M |
| October 31, 2015 | -2.548M |
| July 31, 2015 | -2.913M |
| April 30, 2015 | -3.677M |
| January 31, 2015 | -2.816M |
| October 31, 2014 | -3.078M |
| July 31, 2014 | -3.548M |
| April 30, 2014 | -2.272M |
| January 31, 2014 | -0.574M |
| October 31, 2013 | -2.318M |
| July 31, 2013 | -2.232M |
| April 30, 2013 | -2.046M |
| January 31, 2013 | -0.99M |
| October 31, 2012 | -1.974M |
| July 31, 2012 | -1.323M |
| April 30, 2012 | -2.55M |
| January 31, 2012 | -1.719M |
| October 31, 2011 | -2.349M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-2.566M
Minimum
Jul 2023
0.959M
Maximum
Jan 2021
-0.7202M
Average
-0.319M
Median
Jul 2022
Net Income (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -12.58M |
| Perspective Therapeutics Inc | -12.28M |
| Protalix BioTherapeutics Inc | -4.595M |
| Electromed Inc | 1.493M |
| Armata Pharmaceuticals Inc | -25.02M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.02M |
| Total Expenses (Quarterly) | 14.60M |
| EPS Diluted (Quarterly) | -0.19 |
| Enterprise Value | 59.42M |
| Gross Profit Margin (Quarterly) | 34.70% |
| Profit Margin (Quarterly) | -21.05% |
| Earnings Yield | -15.32% |
| Normalized Earnings Yield | -15.32 |